96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

- Farrell, Michael, Shahbazi, Jeyran, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa, Chambers, Mark, Byrne, Marianne, Gholami, Jaleh, Zahra, Emma, Grebely, Jason, Lintzeris, Nicholas, Larance, Briony, Ali, Robert

A Randomized Trial of Nafamostat for Covid-19

- Morpeth, Susan C., Venkatesh, Balasubramanian, Burke, Andrew J., Cochrane, Belinda, Denholm, Justin T., Dhungana, Ashesh, Dore, Gregory J., Dotel, Ravindra, Duffy, Eamon, Dummer, Jack, Foo, Hong, Gilbey, Timothy L., Totterdell, James A., Hammond, NE, Hudson, BJ, Jha, V, Jevaji, PR, John, O, Joshi, R, Kang, G, Kaur, B, Kim, S, Das, SK, McPhee, Grace M., Lau, JSY, Littleford, R, Marsh, JA, Marschner, IC, Matthews, G, Maze, MJ, McArthur, CJ, McFadyen, JD, McMahon, JH, McQuilten, ZK, Mahar, Robert K., Molton, J, Mora, JM, Mudaliar, V, Nguyen, V, O'Sullivan, MVN, Pant, S, Park, JE, Paterson, DL, Price, DJ, Raymond, N, Jones, Mark, Rees, MA, Robinson, JO, Rogers, BA, Ryu, W-S, Sasadeusz, J, Shum, O, Snelling, TL, Sommerville, C, Trask, N, Lewin, SR, Bandara, Methma, Hills, TE, Davis, Joshua S., Roberts, JA, Tong, SYC, Barina, Lauren A., Basnet, Bhupendra K., Bowen, Asha C.

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

- Cunningham, Evan B., Hajarizadeh, Behzad, Swan, Tracy, Marks, Philippa S., Quiene, Sophie, Applegate, Tanya L., Weltman, Martin, Shaw, David, Dunlop, Adrian, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Dalgard, Olav, Thurnheer, Maria Christine, Dore, Gregory J., Grebely, Jason, Amin, Janaki, Hellard, Margaret, Foster, Graham R., Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert

Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia

- Keats, Julian, Haber, P, Carolyn, D, Gregory, D, Loveday, S, Tawil, V, Krahn, M, Thein, H-H, Micallef, Michelle, Dunlop, Adrian, Grebely, Jason, Hazelwood, Susan, Everingham, Hope, Shrestha, Nikrant, Jones, Tracey, Bath, Nicky, Treloar, Carly, Dore, Gregory J.

Assessment and treatment of Hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study

- Alavi, Maryam, Grebely, Jason, Micallef, Michelle, Dunlop, Adrian J., Balcomb, Annie C., Day, Carolyn A., Treloar, Carla, Bath, Nicky, Haber, Paul S., Dore, Gregory J.

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: the ACTIVATE study

- Midgard, Håvard, Hajarizadeh, Behzad, Hellard, Margaret, Robaeys, Geert, Thurnheer, Marcia C., Weltman, Martin, Amin, Janaki, Marks, Philippa S., Quiene, Sophie, Dore, Gregory J., Dalgard, Olav, Grebely, Jason, Cunningham, Evan B., Conway, Brian, Backmund, Markus, Bruggmann, Philip, Bruneau, Julie, Bourgeois, Stefan, Dunlop, Adrian, Foster, Graham R.

Depression, anxiety, and stress among people with chronic hepatitis C virus infection and a history of injecting drug use in New South Wales, Australia

- Fortier, Emmanuel, Alavi, Maryam, Bath, Nicky, Haber, Paul S., Dore, Gregory J., Grebely, Jason, ETHOS Study Group,, Bruneau, Julie, Micallef, Michelle, Perram, Jacinta, Sockalingam, Sanjeev, Dunlop, Adrian J., Balcomb, Annie C., Day, Carolyn A., Treloar, Carla

Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: analysis from the PREDICT and CHARIOT studies

- Roberts, Stuart K., Mitchell, Joanne, Crawford, Darrell H. G., Sievert, William, Weltman, Martin, Cheng, Wendy, George, Jacob, Leung, Reynold, Booth, David, Bollipo, Steven, Ostapowicz, George, Sloss, Andrew, McCaughan, Geoffrey W., Dore, Gregory J., Thompson, Alexander

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

- Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa

Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

- Cheng, Qinglu, Cunningham, Evan B., Hellard, Margaret, Bruggmann, Philip, Marks, Philippa, Lacombe, Karine, Stedman, Catherine, Read, Phillip, Hajarizadeh, Behzad, Dunlop, Adrian J., Conway, Brian, Feld, Jordan J., Shih, Sophy, Dore, Gregory J., Grebely, Jason, SIMPLIFY and D3FEAT Study Groups,, Amin, Janaki, Bruneau, Julie, Artenie, Adelina A., Powis, Jeff, Litwin, Alain H., Cooper, Curtis, Dalgard, Olav

Predictors of deferral of treatment for hepatitis C infection in Australian clinics

- Gidding, Heather F., Law, Matthew G., Amin, Janaki, MacDonald, Graeme A., Sasadeusz, Joe J., Levett-Jones, Tracy L., Strasser, Simone I., George, Jacob, Dore, Gregory J.

Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study

- Wheeler, Alice, Valerio, Heather, Matthews, Gail V., Dunlop, Adrian J., Gorton, Carla, Hayllar, Jeremy, Alavi, Maryam, Murray, Carolyn, Marks, Phillipa, Silk, David, Degenhardt, Louisa, Dore, Gregory J., Cunningham, Evan B., Grebely, Jason, Martinello, Marianne, Barocas, Joshua A., Colledge-Frisby, Samantha, Treloar, Carla, Amin, Janaki, Henderson, Charles, Read, Phillip

Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study

- Valerio, Heather, Alavi, Maryam, Read, Phillip, Marks, Philippa, Degenhardt, Louisa, Hayllar, Jeremy, Reid, David, Gorton, Carla, Lam, Thao, Dore, Gregory J., Grebely, Jason, Silk, David, Treloar, Carla, Martinello, Marianne, Milat, Andrew, Dunlop, Adrian, Holden, Jo, Henderson, Charles, Amin, Janaki

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study

- Grebely, Jason, Alavi, Maryam, Haber, Paul S., Dore, Gregory J., Micallef, Michelle, Dunlop, Adrian J., Balcomb, Anne C., Phung, Nghi, Weltman, Martin D., Day, Carolyn A., Treloar, Carla, Bath, Nicky